Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosis.

Nature communications·2026

Same author

Building a diagnostic scoring system for high-grade neuroendocrine neoplasms of the pancreas.

American journal of clinical pathology·2026

Same author

CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting.

Nature communications·2026

Same author

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.

Leukemia·2025

Same author

BRD4 and MYB inhibition overcomes venetoclax resistance in EVI1-rearranged acute myeloid leukemia.

Scientific reports·2025

Same author

TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.

Cancer immunology research·2025

Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

[Humanized model for acute myeloid leukemia].

Fumihiko Ishikawa¹

¹Research Unit for Human Disease Models, RIKEN Research Center for Allergy and Immunology.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|October 29, 2009

Summary

This summary is machine-generated.

Researchers created a mouse model of human blood disorders by transplanting human stem cells into newborn mice. This system allows for studying human hematopoiesis, immunity, and blood cancers like AML in vivo.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

Related Experiment Videos

Last Updated: Jun 19, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model

Published on: October 14, 2016

Area of Science:

Immunology
Hematology
Stem Cell Biology

Context:

Investigating human hematopoiesis and immunity in vivo is crucial for understanding disease.
Existing models often fail to fully recapitulate human systems.
The NOD/SCID/IL2rgKO mouse model offers a promising xenotransplantation platform.

Purpose:

To establish a functional human hematopoietic and immune system in mice.
To develop in vivo models for studying human hematological malignancies.
To elucidate the pathophysiology of human Acute Myeloid Leukemia (AML).

Summary:

Human cord blood-derived hematopoietic stem cells (HSCs) were intravenously injected into newborn NOD/SCID/IL2rgKO mice.
This xenotransplantation system supports long-term engraftment, multi-lineage differentiation, and self-renewal of human HSCs.
The model was successfully applied to create in vivo models for human hematological malignancies, including AML.

Impact:

Provides a novel in vivo platform for studying human hematopoiesis and immunity.
Enables detailed investigation into the mechanisms of human hematological malignancies.
Facilitates the development of new therapeutic strategies for AML and other blood disorders.